{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:40:27Z","timestamp":1761896427357,"version":"3.37.3"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T00:00:00Z","timestamp":1482969600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PI12\/01536 and PIE1313\/00033"],"award-info":[{"award-number":["PI12\/01536 and PIE1313\/00033"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"name":"European Regional Development Fund (FEDER)"},{"name":"Red Tem\u00e1tica de Investigaci\u00f3n Cooperativa en C\u00e1ncer","award":["RTICC, RD12\/0036\/0023)"],"award-info":[{"award-number":["RTICC, RD12\/0036\/0023)"]}]},{"name":"Ag\u00e8ncia de Gesti\u00f3 d\u2019Ajuts Universitaris i de Recerca (AGAUR)","award":["2014 SGR 668"],"award-info":[{"award-number":["2014 SGR 668"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1007\/s00277-016-2903-8","type":"journal-article","created":{"date-parts":[[2016,12,29]],"date-time":"2016-12-29T13:37:46Z","timestamp":1483018666000},"page":"405-410","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinico-biological characteristics and outcome of hepatitis C virus-positive patients with diffuse large B-cell lymphoma treated with immunochemotherapy"],"prefix":"10.1007","volume":"96","author":[{"given":"Ivan","family":"Dlouhy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miguel \u00c1.","family":"Torrente","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabela","family":"Lens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordina","family":"Rovira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura","family":"Magnano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Gin\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julio","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Balagu\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"El\u00edas","family":"Campo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xavier","family":"Forns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"S\u00e1nchez-Tapias","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Armando","family":"L\u00f3pez-Guillermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2016,12,29]]},"reference":[{"key":"2903_CR1","doi-asserted-by":"crossref","unstructured":"(1997) A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin\u2019s lymphoma. The Non-Hodgkin\u2019s Lymphoma Classification Project. Blood 89:3909\u20133918.","DOI":"10.1182\/blood.V89.11.3909"},{"key":"2903_CR2","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1182\/blood-2010-03-276246","volume":"116","author":"B Coiffier","year":"2010","unstructured":"Coiffier B, Thieblemont C, Van Den Neste E et al (2010) Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d\u2019Etudes des Lymphomes de l\u2019Adulte. Blood 116:2040\u20132045","journal-title":"Blood"},{"key":"2903_CR3","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3109\/00365549609027143","volume":"28","author":"A Garcia-Fulgueiras","year":"1996","unstructured":"Garcia-Fulgueiras A, Tormo MJ, Rodriguez T et al (1996) Prevalence of hepatitis B and C markers in the south-east of Spain: an unlinked community-based serosurvey of 2, 203 adults. Scand J Infect Dis 28:17\u201320","journal-title":"Scand J Infect Dis"},{"key":"2903_CR4","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.cgh.2008.02.011","volume":"6","author":"S Sanjose de","year":"2008","unstructured":"de Sanjose S, Benavente Y, Vajdic CM et al (2008) Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the international lymphoma epidemiology consortium. Clin Gastroenterol Hepatol 6:451\u2013458","journal-title":"Clin Gastroenterol Hepatol"},{"key":"2903_CR5","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1200\/JCO.2005.01.5016","volume":"24","author":"C Besson","year":"2006","unstructured":"Besson C, Canioni D, Lepage E et al (2006) Characteristics and outcome of diffuse large B-cell lymphoma in hepatitis C virus-positive patients in LNH 93 and LNH 98 Groupe d\u2019Etude des Lymphomes de l\u2019Adulte programs. J Clin Oncol 24:953\u2013960","journal-title":"J Clin Oncol"},{"key":"2903_CR6","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1093\/annonc\/mdl131","volume":"17","author":"C Visco","year":"2006","unstructured":"Visco C, Arcaini L, Brusamolino E et al (2006) Distinctive natural history in hepatitis C virus positive diffuse large B-cell lymphoma: analysis of 156 patients from northern Italy. Ann Oncol 17:1434\u20131440","journal-title":"Ann Oncol"},{"key":"2903_CR7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3324\/haematol.2014.116855","volume":"100","author":"L Arcaini","year":"2015","unstructured":"Arcaini L, Rossi D, Lucioni M et al (2015) The NOTCH pathway is recurrently mutated in diffuse large B-cell lymphoma associated with hepatitis C virus infection. Haematologica 100:246\u2013252","journal-title":"Haematologica"},{"key":"2903_CR8","doi-asserted-by":"crossref","first-page":"835","DOI":"10.3892\/or.2012.1883","volume":"28","author":"H Nishikawa","year":"2012","unstructured":"Nishikawa H, Tsudo M, Osaki Y (2012) Clinical outcome in diffuse large B-cell lymphoma with hepatitis C virus infection in the rituximab era: a single center experience. Oncol Rep 28:835\u2013840","journal-title":"Oncol Rep"},{"key":"2903_CR9","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.leukres.2014.11.015","volume":"39","author":"TT Chen","year":"2015","unstructured":"Chen TT, Chiu CF, Yang TY et al (2015) Hepatitis C infection is associated with hepatic toxicity but does not compromise the survival of patients with diffuse large B cell lymphoma treated with rituximab-based chemotherapy. Leuk Res 39:151\u2013156","journal-title":"Leuk Res"},{"key":"2903_CR10","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1182\/blood-2010-06-289231","volume":"116","author":"D Ennishi","year":"2010","unstructured":"Ennishi D, Maeda Y, Niitsu N et al (2010) Hepatic toxicity and prognosis in hepatitis C virus-infected patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy regimens: a Japanese multicenter analysis. Blood 116:5119\u20135125","journal-title":"Blood"},{"key":"2903_CR11","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1182\/blood-2006-08-038257","volume":"109","author":"LH Sehn","year":"2007","unstructured":"Sehn LH, Berry B, Chhanabhai M et al (2007) The revised international prognostic index (R-IPI) is a better predictor of outcome than the standard IPI for patients with diffuse large B-cell lymphoma treated with R-CHOP. Blood 109:1857\u20131861","journal-title":"Blood"},{"key":"2903_CR12","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1200\/JCO.1999.17.4.1244","volume":"17","author":"BD Cheson","year":"1999","unstructured":"Cheson BD, Horning SJ, Coiffier B et al (1999) Report of an international workshop to standardize response criteria for non-Hodgkin\u2019s lymphomas. NCI sponsored international working group. J Clin Oncol 17:1244","journal-title":"J Clin Oncol"},{"key":"2903_CR13","doi-asserted-by":"crossref","first-page":"489","DOI":"10.3324\/haematol.2013.094318","volume":"99","author":"M Merli","year":"2014","unstructured":"Merli M, Visco C, Spina M et al (2014) Outcome prediction of diffuse large B-cell lymphomas associated with hepatitis C virus infection: a study on behalf of the Fondazione Italiana Linfomi. Haematologica 99:489\u2013496","journal-title":"Haematologica"},{"key":"2903_CR14","unstructured":"Alonso Lopez S, Agudo Fernandez S, Garcia Del Val A, et al. [Hepatitis C seroprevalence in an at-risk population in the southwest Madrid region of Spain]. Gastroenterol Hepatol 2016."},{"key":"2903_CR15","doi-asserted-by":"crossref","first-page":"278","DOI":"10.4254\/wjh.v3.i11.278","volume":"3","author":"AM Pellicelli","year":"2011","unstructured":"Pellicelli AM, Marignani M, Zoli V et al (2011) Hepatitis C virus-related B cell subtypes in non Hodgkin\u2019s lymphoma. World J Hepatol 3:278\u2013284","journal-title":"World J Hepatol"},{"key":"2903_CR16","doi-asserted-by":"crossref","unstructured":"Hosry J, Mahale P, Turturro F, et al. (2016) Antiviral therapy improves overall survival in hepatitis C virus-infected patients who develop diffuse large B-cell lymphoma. Int J Cancer.","DOI":"10.1002\/ijc.30372"},{"key":"2903_CR17","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1002\/ajh.23889","volume":"90","author":"JM Michot","year":"2015","unstructured":"Michot JM, Canioni D, Driss H et al (2015) Antiviral therapy is associated with a better survival in patients with hepatitis C virus and B-cell non-Hodgkin lymphomas, ANRS HC-13 lympho-C study. Am J Hematol 90:197\u2013203","journal-title":"Am J Hematol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2903-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00277-016-2903-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-016-2903-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,28]],"date-time":"2020-09-28T10:22:36Z","timestamp":1601288556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00277-016-2903-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,29]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["2903"],"URL":"https:\/\/doi.org\/10.1007\/s00277-016-2903-8","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2016,12,29]]}}}